Kevan M. Shokat, PhD, shifted the paradigm of targeted cancer therapy by drugging an “undruggable” protein and paving the way for future advances.
After a cancer diagnosis, people who are deaf or have hearing problems can struggle if accommodations don’t meet their communication needs.
by Eric Fitzsimmons
Is Immunotherapy Right for People Hospitalized With Advanced Cancer?Researchers find no evidence that immune checkpoint inhibitors benefit cancer patients getting inpatient care. They urge earlier consideration of palliative care.
by Kyle Bagenstose
Celebrity Cancer Stories Can Lack Important InformationNews coverage about public figures facing cancer frequently leaves out key details about the diagnosis and fails to provide background information on cancer.
by Laura Gesualdi Gilmore
AACR Annual Meeting 2025Immunotherapies, cancer vaccines and more from Cancer Today’s coverage of the AACR Annual Meeting 2025.
-
From Discovery to SurvivorshipThe upcoming AACR Patient Advocate Forum will explore how advanced technologies are transforming cancer care, with a focused lens on immunotherapy, precision oncology, imaging, and survivorship.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Cancer Research at a Crossroads
